Please login to the form below

Not currently logged in

loss of exclusivity

This page shows the latest loss of exclusivity news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly shares adjusted financial guidance for 2023

Eli Lilly shares adjusted financial guidance for 2023

its loss of patent exclusivity and no expected COVID-19 antibody revenue. ... Lilly also took into account the continued negative affect of foreign exchange rates.

Latest news

More from news
Approximately 0 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    The loss of exclusivity for Lipitor continued to have a major impact, but alongside this, a further 24 of its therapies suffered a drop in sales. ... in an attempt to mirror the success of Roche and its Genentech subsidiary.”.

  • Who tops the pharma list? Who tops the pharma list?

    Loss of exclusivity on some of its leading brands - not least Lipitor - contributed to an overall dip in revenue of more than $6.5bn from 2011. ... In fact, patent expiry was an industry-wide epidemic in 2011/12, with loss of exclusivity plaguing many of

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Major products were about to lose, or had just lost, their patent exclusivity.”. ... For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.

  • The true meaning of market access? The true meaning of market access?

    Appropriate patients. Payers want predictability of patient outcomes and certainty of budget impact. ... Market access is everyone's responsibility throughout the life of the medicine from early phase R&D right through to loss of exclusivity.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...